Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Citron

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2017
An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous CarcinomaFrancesca Citron, Joshua Armenia, Giovanni Franchin, et al.
EMBO Molecular Medicine|June 1, 2021
miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCCFrancesca Citron, Ilenia Segatto, Lorena Musco, et al.
Science Advances|March 27, 2024
Activation of endogenous retroviruses and induction of viral mimicry by MEK1/2 inhibition in pancreatic cancerAlice Cortesi, Francesco Gandolfi, Fabiana Arco, et al.
Cancer Research|December 2, 2025
GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic AdenocarcinomaZiheng Chen, I-Lin Ho, Jintan Liu, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2023
Evolutionary fingerprints of EMT in pancreatic cancersLuigi Perelli, Li Zhang, Sarah Mangiameli, et al.
Cell Reports. Medicine|July 27, 2025
Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancersMadelaine S Theardy, Mitsunobu Takeda, Alexey Sorokin, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Therapeutic targeting of Syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancersMitsunobu Takeda, Madelaine S Theardy, Alexey Sorokin, et al.
Cancers|October 23, 2021
Evaluation of Angiogenesis-Related Genes as Prognostic Biomarkers of Bevacizumab Treated Ovarian Cancer Patients: Results from the Phase IV MITO16A/ManGO OV-2 Translational StudyDaniela Califano, Daniela Gallo, Gian Luca Rampioni Vinciguerra, et al.
The Journal of Pathology|November 3, 2020
CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancerDavide Viotto, Francesca Russo, Ilaria Anania, et al.
Science (New York, N.Y.)|September 16, 2021
Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesisEdoardo Del Poggetto, I-Lin Ho, Chiara Balestrieri, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2017
An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous CarcinomaFrancesca Citron, Joshua Armenia, Giovanni Franchin, et al.
EMBO Molecular Medicine|June 1, 2021
miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCCFrancesca Citron, Ilenia Segatto, Lorena Musco, et al.
Science Advances|March 27, 2024
Activation of endogenous retroviruses and induction of viral mimicry by MEK1/2 inhibition in pancreatic cancerAlice Cortesi, Francesco Gandolfi, Fabiana Arco, et al.
Cancer Research|December 2, 2025
GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic AdenocarcinomaZiheng Chen, I-Lin Ho, Jintan Liu, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2023
Evolutionary fingerprints of EMT in pancreatic cancersLuigi Perelli, Li Zhang, Sarah Mangiameli, et al.
Cell Reports. Medicine|July 27, 2025
Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancersMadelaine S Theardy, Mitsunobu Takeda, Alexey Sorokin, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Therapeutic targeting of Syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancersMitsunobu Takeda, Madelaine S Theardy, Alexey Sorokin, et al.
Cancers|October 23, 2021
Evaluation of Angiogenesis-Related Genes as Prognostic Biomarkers of Bevacizumab Treated Ovarian Cancer Patients: Results from the Phase IV MITO16A/ManGO OV-2 Translational StudyDaniela Califano, Daniela Gallo, Gian Luca Rampioni Vinciguerra, et al.
The Journal of Pathology|November 3, 2020
CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancerDavide Viotto, Francesca Russo, Ilaria Anania, et al.
Science (New York, N.Y.)|September 16, 2021
Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesisEdoardo Del Poggetto, I-Lin Ho, Chiara Balestrieri, et al.
Pageof 3